NUBLOSSENT
Trademark domain | |
name | is free? |
---|---|
nublossent.com | ![]() |
The "NUBLOSSENT" trademark, serial number 78669135 , was filed on 13th of July 2005 with a mark drawing code of 4000 and its transaction date is 78669135. The attorney assigned is Maury M. Tepper, III, attorney docket number 51653. Since 31st of December 2009, the document can be found in the L30 law office in the publication and issue section. The employee responsible is LAMOTHE, LESLEY and the date it was published for opposition on 03/28/2006. The status of the trademark was checked last on 07/20/2009.
Other trademarks by this attorney include , DIGGER, EL DERMATOFITO , DIGGER, EL DERMATOFITO . The corresponded responsible for this trademark is Maury M. Tepper, III, located at Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh NC 27609.The state or country where the trademark was organized is by Novartis Ag. The legal entity type behing it is a Corporation, located at 4002, Basel, zip .Other trademarks by this applicant: NUBLOXIN, DIGGER, EL DERMATOFITO, INTERCEPTOR SPECTRUM.
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 07/19/2005 |
Primary Code | 005 |
Goods codes | |
GS0051 | Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacteria-based diseases, antivirals, anti-biotics, anti-fungals |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
12/16/2008 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
07/20/2009 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
06/19/2007 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
07/20/2009 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | O - Outgoing Correspondence | MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | |
06/19/2009 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
12/16/2008 | EXTENSION 5 GRANTED | S | EX5G - EXTENSION 5 GRANTED | |
12/16/2008 | EXTENSION 5 FILED | S | EXT5 - EXTENSION 5 FILED | |
06/16/2008 | EXTENSION 4 GRANTED | S | EX4G - EXTENSION 4 GRANTED | |
06/16/2008 | EXTENSION 4 FILED | S | EXT4 - EXTENSION 4 FILED | |
06/16/2008 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
12/17/2007 | EXTENSION 3 GRANTED | S | EX3G - EXTENSION 3 GRANTED | |
12/17/2007 | EXTENSION 3 FILED | S | EXT3 - EXTENSION 3 FILED | |
12/17/2007 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
10/10/2007 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
06/19/2007 | EXTENSION 2 GRANTED | S | EX2G - EXTENSION 2 GRANTED | |
06/19/2007 | EXTENSION 2 FILED | S | EXT2 - EXTENSION 2 FILED | |
12/05/2006 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
12/05/2006 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
12/05/2006 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
06/20/2006 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
03/28/2006 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
03/08/2006 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
02/13/2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
02/10/2006 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
02/08/2006 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
02/02/2006 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
11/16/2005 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
07/19/2005 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM |
The "NUBLOSSENT" trademark, serial number 77768195 , was filed on 25th of June 2009 with a mark drawing code of 4000 and its transaction date is 77768195. The attorney assigned is Maury M. Tepper, III, attorney docket number . Since 31st of December 2009, the document can be found in the M40 law office in the publication and issue section. The employee responsible is DAHLING, KRISTIN M and the date it was published for opposition on 09/29/2009. The date when we last checked the status of this trademark was 12/22/2009.
Other trademarks by this attorney include , XYOTAX , BIFLO , BREEZHALER . The corresponded responsible for this trademark is MAURY M. TEPPER, III, located at TEPPER & EYSTER, PLLC, 3724 BENSON DR, RALEIGH, NC 27609-7321.The state or country where the trademark was organized is by Novartis Ag. The legal entity type behing it is a Corporation, located at Ch-4002, Basel, zip .
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 06/29/2009 |
Primary Code | 005 |
Goods codes | |
GS0051 | Anti-infectives; Antibiotics; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
12/22/2009 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
09/29/2009 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
09/09/2009 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
08/27/2009 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
08/27/2009 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
08/24/2009 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
08/18/2009 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
06/29/2009 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
06/29/2009 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.